Plasmodium vivax vaccine candidate MSP1 displays conserved B-cell epitope despite high genetic diversity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasmodium vivax vaccine candidate MSP1 displays conserved B-cell epitope despite high genetic diversity

Published:2021-09 Issue: Volume:93 Page:104929
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Ghoshal Sharmistha,Datta Kanjilal Sumana,Sengupta Sanghamitra

Funder

Council of Scientific and Industrial Research, India

Department of Biotechnology, Government of West Bengal

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference23 articles.

1. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians;Bastos;Clin. Vaccine Immunol.,2007

2. Diversity analysis of MSP1 identifies conserved epitope organization in block 2 amidst high sequence variability in Indian Plasmodium falciparum isolates;Ghoshal;Malar. J.,2018

3. Failure of supervised Chloroquine and Primaquine regimen for the treatment of Plasmodium vivax in the Peruvian Amazon;Graf;Malar. Res. Treat.,2012

4. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1;Imwong;Malar. J.,2005

5. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India;Kale;Malar. J.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LEVERAGING THE SUCCESS OF MRNA LIPID NANOPARTICLE VACCINE IN COVID-19 TREATMENT: A NARRATIVE REVIEW ON ITS POTENTIAL APPLICATION IN MALARIA TREATMENT;International Journal of Applied Pharmaceutics;2024-06-07

2. Pathogenesis of Plasmodium falciparum;Drug Targets for Plasmodium Falciparum: Historic to Future Perspectives;2024

3. Host-parasite interactions during Plasmodium infection: Implications for immunotherapies;Frontiers in Immunology;2023-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3